Aug 2026· Nucleic Acid Insights· Vol 3, pp. 455–460· 0 citations
TL;DR
The unique chemical modification challenges involved in stabilizing microRNA therapeutics without disrupting their natural biology are spoken to, alongside the major delivery hurdles, particularly endosomal escape, facing the field.
Abstract
“RNA therapeutics as a whole have garnered a great deal of attention, and I think it is the next frontier of therapeutics.” Jokūbas Leikauskas, Editor, Nucleic Acid Insights , speaks to Shreyas Iyer, Graduate Student Researcher, Purdue University, about the unique chemical modification challenges involved in stabilizing microRNA therapeutics without disrupting their natural biology, alongside the major delivery hurdles, particularly endosomal escape, facing the field. They close by outlining targeted delivery, endosomal escape, and deeper mechanistic understanding as the key areas poised to advance microRNA therapeutics over the next decade.
The unique properties of saRNA have positioned it as an innovative tool for the treatment of various diseases, unlocking more possibilities for clinical applications and outlining future directions for the field.
Yan Zong, Chan-Yuan Jin, Qiang Cheng· Small· 0 citations
The different forms of RNA-based treat-ments, such as messenger RNAs, small interfering RNAs, and circular RNAs, are discussed in this paper along with their significance in gene regulation and the treatment of disease.
Avinash Verma, Shaweta Sharma· Drug Delivery Letters· 0 citations
RNA-based therapeutics have enabled drug discovery and design by introducing a fundamentally different perspective from conventional therapeutics. RNAs are not only the upstream molecules of proteins (coding) but also functional components of an extensive and intricate regulatory network (noncoding) that helps govern b...
Barbara Yang, Melina J. Sedano, Karla Perez et al.· Signal Transduction and Targ...· 0 citations
PIKfyve inhibitors have evolved from niche probes into powerful tools for studying endolysosomal biology. Although PIKfyve inhibition has revealed important roles in membrane trafficking, autophagy, viral entry, and cancer‐cell vulnerability, clinical translation remains limited by a narrow therapeutic window because d...
Athavan Alias Anand Selvam, Anamika Sharma· Chemical Biology and Drug De...· 0 citations
Significant challenges remain for its broad applicability as a potential curative therapy for human genetic diseases, mainly related to ensuring efficient and safe delivery to target tissues.
Emilio M. García-Tenorio, Mar Álvarez, Eva Richard et al.· Methods in molecular biology· 0 citations
“Sharing what works, what does not, what is safe, and what is not would advance the field considerably…”Jokūbas Leikauskas, Editor, Nucleic Acid Insights , speaks with Annemieke Aartsma-Rus, Professor of Translational Genetics, Leiden University Medical Center, about why delivery remains the central challenge in exon s...
